| Serial Number | 98247335 |
| Word Mark | BEACON THERAPEUTICS |
| Filing Date | Monday, October 30, 2023 |
| Status | 661 - RESPONSE AFTER NON-FINAL ACTION - ENTERED |
| Status Date | Wednesday, January 22, 2025 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 5 - Drawing with word(s) / letter(s) / number(s) in Stylized form |
| Published for Opposition Date | NOT AVAILABLE |
| Description of Mark | The mark consists of the stylized blue text 'BEACON" above the stylized blue text "THERAPEUTICS". The letter "O" in the word "BEACON" is replaced by a circle design made up of six inward-pointing blue triangles. |
| Indication of Colors claimed | The color(s) blue is/are claimed as a feature of the mark. |
| NOT AVAILABLE | "THERAPEUTICS" |
| Goods and Services | Research and development services in the fields of pharmaceutical preparations and substances for the treatment of disorders relating to the eye, biotechnological preparations for the treatment of disorders relating to the eye, preparations for gene therapy and cell therapy for the treatment of disorders relating to the eye and genetic medicines for the treatment of disorders relating to the eye; consulting services for others in the field of design planning and implementation project management of clinical trials in the fields of pharmaceutical preparations and substances for the treatment of disorders relating to the eye, biotechnological preparations for the treatment of disorders relating to the eye, preparations for gene therapy and cell therapy for the treatment of disorders relating to the eye and genetic medicines for the treatment of disorders relating to the eye; scientific research in the nature of conducting clinical trials for others in the fields of pharmaceutical preparations and substances for the treatment of disorders relating to the eye, biotechnological preparations for the treatment of disorders relating to the eye, preparations for gene therapy and cell therapy for the treatment of disorders relating to the eye and genetic medicines for the treatment of disorders relating to the eye |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, November 8, 2023 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Beacon Therapeutics Limited |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 24 - NOT AVAILABLE |
| Address | London N79AS |
| Event Date | Event Description |
| Thursday, November 2, 2023 | NEW APPLICATION ENTERED |
| Wednesday, November 8, 2023 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Saturday, June 15, 2024 | NON-FINAL ACTION E-MAILED |
| Saturday, June 15, 2024 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Saturday, June 15, 2024 | NON-FINAL ACTION WRITTEN |
| Tuesday, June 11, 2024 | ASSIGNED TO EXAMINER |
| Monday, September 16, 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Monday, September 16, 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Monday, September 16, 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Tuesday, October 22, 2024 | NON-FINAL ACTION E-MAILED |
| Tuesday, October 22, 2024 | NON-FINAL ACTION WRITTEN |
| Tuesday, October 22, 2024 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Wednesday, January 22, 2025 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Wednesday, January 22, 2025 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Wednesday, January 22, 2025 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |